LOTAGEN ASTRINGENT/ANTISEPTIC CONCENTRATE

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Patient Information leaflet (PIL)

19-06-2017

Summary of Product characteristics (SPC)

19-06-2017

Active ingredient:

METACRESOLSULFONIC ACID-FORMALDEHYDE

Available from:

INTERVET AUSTRALIA PTY LIMITED

INN (International Name):

metacresolsulfonic acid-form(414mg/mL)

Pharmaceutical form:

TOPICAL SOLUTION/SUSPENSION

Composition:

METACRESOLSULFONIC ACID-FORMALDEHYDE EMULSIFIERS & SURFACTANTS Active 414.0 mg/ml

Units in package:

1000mL; 100mL

Class:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

Therapeutic group:

Therapeutic area:

DERMATOLOGICAL PREPS.

Therapeutic indications:

Product summary:

Poison schedule: 6; Withholding period: WHP: MEAT: Do not use less than 28 days before slaughter for human consumption .; Host/pest details: ANIMAL: [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; CAT: [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; COW: [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; DOG: [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; HORSE MARE (FEMALE): [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; PIG SOW (FEMALE): [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; SHEEP EWE (FEMALE): [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; Poison schedule: 6; Withholding period: ; Host/pest details: ANIMAL: [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; CAT: [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; COW: [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; DOG: [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; HORSE MARE (FEMALE): [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; PIG SOW (FEMALE): [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; SHEEP EWE (FEMALE): [AGENT ACTING ON UTERUS, CRACKS, SORES, WOUNDS (ASSIST HEALING)]; For the treatment of fresh or old wounds, to promote healing and prevent excessive granulation in all species.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

File Name:
35967_0702c.doc
Prepared By:
L. Wirth
Preparation Date:
9/7/2002
Last Revised:
14/2/2001
Schering-Plough Label & Printer
Specifications:
CCP 02/023
Version:
1
Page 1 of 9
PRIMARY PACK
LOTAGEN CONCENTRATE
100mL CARTON – MAIN PANEL
POISON
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
FOR ANIMAL TREATMENT ONLY
LOTAGEN®
ASTRINGENT/ANTISEPTIC CONCENTRATE
ACTIVE CONSTITUENTS PER ML:
METACRESOLSULPHONIC ACID AND
FORMALDEHYDE CONDENSATION PRODUCT
414 MG
For the treatment of fresh or old wounds, to promote
healing and prevent excessive granulation in all species.
100ML
Schering-Plough Animal Health
PRIMARY PACK
LOTAGEN CONCENTRATE
100mL CARTON – SIDE PANEL
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
DIRECTIONS FOR USE:
PRECAUTION: DO NOT BRING LOTAGEN INTO CONTACT WITH TEXTILES OR
LEATHER.
For new and old wounds, excessive bleeding, prevention of “proud
flesh” paint with Lotagen
Concentrate daily. The best methods are to bandage swabs soaked in
Lotagen to the wound, or
preferably to apply with a spraying bottle.
PUERPERAL DISORDERS: IRRIGATE WITH A 4% SOLUTION.
ENDOMETRITIS IN COWS, SOWS AND EWES: INSTIL 4% SOLUTION TO STIMULATE
UTERINE
TONE.
INTRAUTERINE USE IN MARES: 1-2% SOLUTION.
INTRAUTERINE USE IN SOWS: 2% SOLUTION.
WITHHOLDING PERIOD:
MEAT: DO NOT USE LESS THAN 28 DAYS BEFORE SLAUGHTER FOR HUMAN
CONSUMPTION.
Info
PEST

Verified
File Name:
35967_0702c.doc
Prepared By:
L. Wirth
Preparation Date:
9/7/2002
Last Revised:
14/2/2001
Schering-Plough Label & Printer
Specifications:
CCP 02/023
Version:
1
Page 2 of 9
PRIMARY PACK
LOTAGEN CONCENTRATE
100mL CARTON – SIDE PANEL
SAFETY DIRECTIONS
WILL IRRITATE THE EYES. MAY IRRITATE THE SKIN. AVOID CONTACT WITH EYES
AND SKIN. IF PRODUCT ON
SKIN, IMMEDIATELY WASH AREA WITH SOAP AND WATER. IF PRODUCT IN EYES,
WASH IT OUT IMMEDIATELY
WITH WATER. WASH HANDS AFTER USE.
FIRST AID
IF POISONING OCCURS CONTACT A DOCTOR OR POISONS INFORMATION CENTRE
(PHONE 131126). IF
SWALLOWED DO NOT INDUCE VOMITING. GIVE A GLASS OF WATER.
WARR

Read the complete document

Summary of Product characteristics

PRODUCT NAME: LOTAGEN ASTRINGENT ANTISEPTIC CONCENTRATE
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: AUGUST, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Water based preparation.
TRADE NAME:
LOTAGEN ASTRINGENT ANTISEPTIC CONCENTRATE
RECOMMENDED USE:
For the treatment of wounds with astringent, bactericidal, fungicidal
and debriding
properties. For the treatment of animals only.
APVMA NO:
35967
CREATION DATE:
August, 2009
THIS VERSION ISSUED:
August, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Xi, Irritating. Hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
R38, R41. Irritating to skin. Risk of serious damage to eyes.
SAFETY PHRASES:
S2, S26, S28, S24/25, S36/39. Keep out of reach of children. In case
of contact with eyes, rinse
immediately with plenty of water and contact a doctor or Poisons
Information Centre. After contact with skin, wash
immediately with plenty of soap and water. Avoid contact with skin and
eyes. Wear suitable protective clothing and
eye/face protection.
SUSDP CLASSIFICATION:
S6
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Clear, reddish-brown aqueous solution.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
may cause serious damage to eyes, skin irritant.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. However
product may be mildly
irritating, although unlikely to cause anything more than mild
transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is a likely skin irritant.
Symptoms may include
itchiness and re

Read the complete document